Why the study?
Are Gc globulin and prealbumin serum levels altered in patients with cancer or benign inflammatory diseases compared to healthy smokers?
Population
200 individuals, comprising 100 patients with cancer, 50 patients with benign inflammatory diseases from the…
Design
Cross-sectional, coded serum panel
Authors
Loading...
Prealbumin levels were lower in cancer and inflammation; leaves open its biomarker utility in smokers pending prospective validation.
Are Gc globulin and prealbumin serum levels altered in patients with cancer or benign inflammatory diseases compared to healthy smokers?
Prealbumin, but not Gc globulin, serum levels are decreased in patients with cancer and benign inflammatory diseases compared to healthy smokers.
Rostenberg et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: